Skip to main content
Denmark
Global Fin Swe Nor Den Ger Cze Svk Pol Hun Nld Bel (nl) Bel (fr) USA
  • Aidian – Your aid in diagnostics
  • Produkter
  • Om os
  • Nyheder
  • Instrument service
  • Antimicrobial resistance
  • Messer og udstillinger
  • Aidian Academy
  • Kunde historier
Kontakt os Søg
Logo
Kontakt os
  • Point of care
  • Mikrobiologi
  • Molekylær mikrobiologi
  • Hygiejneovervågning
  • RIA / Collagener
  • Luftvejsinfektioner
  • Andre
Point of care
  • QuikRead go-systemet
  • microINR
  • Certest
  • FACIT
  • SD BIOSENSOR STANDARD F
  • bioLytical Laboratories INSTI®
  • Nova Biomedical
  • ACRO™ Biotech
  • Hangzhou AllTest Biotech
Læs mere
QuikRead go
  • QuikRead go Plus Instrument
  • QuikRead go Instrument
  • QuikRead go easy CRP
  • QuikRead go CRP
  • QuikRead go CRP+Hb
  • QuikRead go wrCRP
  • QuikRead go wrCRP+Hb
  • QuikRead go HbA1c
  • QuikRead go Strep A
  • QuikRead go iFOBT
  • QuikRead go tilbehør
QuikRead go
Mikrobiologi
  • Uricult / Uricult Trio-tests
  • Uricult Vet
  • Cultura M
  • MIKROGEN serologi
  • Meridian Immunoassays
  • Meridian Curian®
  • Reagena
Læs mere
Molekylær mikrobiologi
  • Meridian Revogene®
  • Meridian Alethia®
  • MIKROGEN molecular diagnostics
  • SD BIOSENSOR STANDARD M10
Læs mere
Hygiejneovervågning
  • Easicult
  • Hygicult
  • Clean Card PRO
Læs mere
RIA / Collagener
  • UniQ RIA
Læs mere
Andre
  • Grifols Promonitor®
Læs mere
  • Aidian i Danmark
  • Bestyrelse og direktion
  • Bæredygtighed
  • Kultur
  • Karriere
  • Nyheder
  • Produktnyheder
  • AMR
  • Begivenheder
  • Stories from customers
  • COVID-19
  • Om C-reaktivt protein (CRP)
  • CRP and lower respiratory tract infections
  • Understøttende materialer
  • QuikRead go CRP products
  • Spreading of antibiotic resistant bacteria
  • Useful links
  • Generally
  • Product information
  • Documents and materials
  • Frequently asked questions
  • Sovehygiejne: overvågning af renlighed af puder og sengetøj
Logo
Kontakt os Tæt
  • Produkter
    • Point of care
      • QuikRead go-systemet
      • microINR
      • Certest
      • FACIT
      • SD BIOSENSOR STANDARD F
      • bioLytical Laboratories INSTI®
      • Nova Biomedical
      • ACRO™ Biotech
      • Hangzhou AllTest Biotech
    • Mikrobiologi
      • Uricult / Uricult Trio-tests
      • Uricult Vet
      • Cultura M
      • MIKROGEN serologi
      • Meridian Immunoassays
      • Meridian Curian®
      • Reagena
    • Molekylær mikrobiologi
      • Meridian Revogene®
      • Meridian Alethia®
      • MIKROGEN molecular diagnostics
      • SD BIOSENSOR STANDARD M10
    • Hygiejneovervågning
      • Easicult
      • Hygicult
      • Clean Card PRO
    • RIA / Collagener
      • UniQ RIA
    • Luftvejsinfektioner
    • Andre
      • Grifols Promonitor®
  • Om os
    • Aidian i Danmark
    • Bestyrelse og direktion
    • Bæredygtighed
    • Kultur
    • Karriere
  • Nyheder
    • Nyheder
    • Produktnyheder
    • AMR
    • Begivenheder
    • Stories from customers
    • COVID-19
  • Instrument service
  • Antimicrobial resistance
    • Om C-reaktivt protein (CRP)
    • CRP and lower respiratory tract infections
    • Understøttende materialer
    • QuikRead go CRP products
    • Spreading of antibiotic resistant bacteria
    • Useful links
  • Messer og udstillinger
  • Aidian Academy
    • Generally
    • Product information
    • Documents and materials
    • Frequently asked questions
  • Kunde historier
    • Sovehygiejne: overvågning af renlighed af puder og sengetøj
Populære produkter
AllTest hCG hurtig test

AllTest hCG hurtig test

AllTest MONO hurtig test

AllTest MONO hurtig test

Acro Strep A hurtig test

Acro Strep A hurtig test

Seneste nyt
Se alt

Are you prepared for tick season?

9. april 2025 | Nyheder, Produktnyheder

Vi præsenterer QuikRead go Plus Instrument!

20. januar 2025 | Nyheder, Produktnyheder

Increase in influenza and RSV activity in the EU/EEA

14. januar 2025 | Nyheder

  • Se alt
  • Ingen resultater fundet
  • Loading...
Nyheder

Are you prepared for tick season?

9. april 2025 | Nyheder, Produktnyheder

Vi præsenterer QuikRead go Plus Instrument!

20. januar 2025 | Nyheder, Produktnyheder

Tilbage til alle nyheder
23. august 2022
Nyheder,
AMR,
COVID-19

COVID-19 pandemic has contributed to the aggravation of Antimicrobial Resistance

Antimicrobial resistance (AMR) is an emerging health threat, but the COVID-19 pandemic set back many actions already combating AMR. Before COVID-19, Antimicrobial stewardship programs and National Actions Plans significantly progressed to slow down Antimicrobial Resistance in many countries. Due to the emergency in the healthcare systems caused by COVID-19, many planned activities were deprioritized and already integrated preventive actions were reversed1,2. For example, antibiotics were prescribed more often without diagnostic confirmation about bacterial infection than before the pandemic1,3.

Recently, the US Centers for Disease Control and Prevention reported that after several years of decrease, antimicrobial resistant hospital-onset infections and deaths increased by at least 15% during the first year of the pandemic. The change in trend indicates that AMR preventive actions must be readdressed and integrated back into the healthcare systems.

Antibiotics were commonly prescribed for hospitalized COVID-19 patients

Antibiotics do not cure viral infections, such as COVID-19, but bacterial co-infections may sometimes accompany viral infections. Treating COVID-19 patients with antibiotics, especially in the early pandemic, seemed to be rather a rule than an exception in many countries. There were concerns about bacterial co-infections, and difficulties in differentiating COVID-19 from community-acquired pneumonia that led excessive antibiotic use. In the USA and China, 80-100% of hospitalized COVID-19 patients received antibiotics1,4. However, bacterial co-infections were reported only on 7-8% of hospitalized and 14% of intensive care patients4, which suggests that antibiotics were often inappropriately used in the treatment of COVID-19.

A person holding a medicine bottle and a pill

The use of broad-spectrum antibiotics increased during COVID-19

In primary care, overall antibiotic consumption decreased in many countries during COVID-19 due to fewer visits to primary care and less spread of respiratory infection. However, the consumption of broad-spectrum antibiotics increased in the EU/EEA countries in both primary care and hospitals.5 Also, in the USA, broad-spectrum antibiotics were commonly used in hospitalized COVID-19 patients1. Broad-spectrum antibiotics are effective against a wide range of bacteria. They are not a first option treatment: they should be used only to treat severe bacterial infections. Therefore, it is necessary to use them correctly to prevent the development of resistance to these drugs.

Immediate actions are needed to optimize antibiotic use and prevent AMR

Now it is more urgent than ever to focus on AMR and reinforce antimicrobial stewardship programs to ensure the appropriate use of antibiotics and other AMR preventive actions in healthcare. Performing fast and accurate point of care tests before antibiotic prescribing, such as QuikRead go CRP and Strep A tests, are an efficient way to optimize antibiotic prescribing and prevent the development of antibiotic resistant bacteria.

Find our portfolio for CRP and Strep A point of care tests from our website: Point of care / QuikRead go


References

  1. Centers of Disease Control and Prevention (CDC). COVID-19: U.S. Impact on Antimicrobial Resistance, Special report 2022. Atlanta, GA: U.S. Department of Health and Human Services. https://www.cdc.gov/drugresistance/pdf/covid19-impact-report-508.pdf
  2. Pan American Health Organization. Antimicrobial Resistance, Fueled by the COVID-19 Pandemic. Policy Brief November 2021. https://iris.paho.org/handle/10665.2/55864
  3. Mantzourani et al. To swab or not to swab? Using point-of-care tests to detect Group A Streptococcus infections as part of a Sore Throat Test and Treat service in community pharmacy. J Antimicrobial Chemoter 2021; 77:803–806.
  4. Lansbury et al. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect 2020;81(2):266–275.
  5. Organisation for Economic Co-operation and Development (OECD), European Centre for Disease Control and Prevention (ECDC), European Food Safety Authority (EFSA) and European Medicines Agency (EMA). Briefing note: Antimicrobial Resistance in the EU/EEA: A One Health Response. 2022.
Share
Facebook
Twitter
E-mail

Aidian Denmark ApS

Ørestads Boulevard 73,
2300 København S


+45 8610 3020


Forespørgsler
info@aidian.dk


Salg
order@aidian.dk

Selskab
  • Om os
  • Bæredygtighed
  • Karriere
  • Kontakt os
Produkter
  • Point of care
  • Mikrobiologi
  • Molekylær mikrobiologi
  • Hygiejneovervågning
  • RIA / Collagener
  • Luftvejsinfektioner
  • Andre
Hurtige links
  • Aidian Academy
Copyright © 2025 Aidian
  • Persondatapolitik
  • Erklæring om beskyttelse af persondata
  • Cookie-politik
  • Sociale medier politik